Volume 97, Issue 3 pp. 361-370
Article
Full Access

Methionine metabolism in BHK cells: Preliminary characterization of the physiological effects of cycloleucine, an inhibitor of S-adenosylmethionine biosynthesis

Dr. Michel Caboche

Corresponding Author

Dr. Michel Caboche

Laboratoire de Génétique Cellulaire, Institut National de la Recherche Agronomique, BP 12, 31320 Castanet Tolosan, France

Lab. biologiè Cellulaire, CNRA, 78000 Versailles, FranceSearch for more papers by this author
Jacques Hatzfeld

Jacques Hatzfeld

Institut de Biologie Moléculaire, Université Paris 7, 2 Place Jussieu, 75221 Paris Cedex 05, France

Search for more papers by this author
First published: December 1978
Citations: 15

Abstract

Cycloleucine is in vitro a competitive inhibitor of methionine adenosyltransferase, an enzyme involved in S-adenosylmethionine biosynthesis. The physiological effects of this drug on baby hamster kidney cells have been studied. When cells are grown in a medium containing 10 μM methionine, cycloleucine is an inhibitor of cell proliferation; high concentrations of methionine are able to withdraw this inhibition suggesting that cycloleucine toxicity is related to methionine metabolism. The drug does not primarily affect methionine uptake and its subsequent use for protein biosynthesis. Cycloleucine toxicity is correlated with a block of SAM biosynthesis and nucleic acids methylations. The actions of cycloleucine on progression in the cell cycle and DNA, RNA and protein biosynthesis are studied. The implications of these results are discussed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.